More importantly, DDX3 directly interacts with the p21waf1/cip1 (a cyclin-dependent kinase inhibitor) promoter through its four SP1 sites (located within the -123 to -63 region) and utilizes ATPase-dependent activity to inhibit the colony formation ability of various tumour cells [11–14]. Here, DDX3X is linked to neoplasm.